| Literature DB >> 23545521 |
Abstract
Patients with elderly-onset IBD are more likely to have marked comorbidities and polypharmacy than those diagnosed at a younger age, which might affect therapeutic decision-making. Increased knowledge of this higher-risk group might guide patient management. Data from a large population-based study evaluating the clinical presentation and course of elderly-onset IBD are discussed.Entities:
Mesh:
Year: 2013 PMID: 23545521 DOI: 10.1038/nrgastro.2013.56
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN: 1759-5045 Impact factor: 46.802